Mary Cooley Ph.D. R.N.
Instructor, Department of Psychiatry, Harvard Medical School
Nurse Scientist, Nursing and Patient Care, Dana-Farber Cancer Institute
Contact Info
Mary Cooley
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: G220
Phone: 6176324653
Fax: 6176325636
mary_cooley@dfci.harvard.edu
Phone: 6176321925
Fax: 6176325636
rsalazar@partners.org
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: G220
Phone: 6176324653
Fax: 6176325636
mary_cooley@dfci.harvard.edu
Assistant
Romelia SalazarPhone: 6176321925
Fax: 6176325636
rsalazar@partners.org
DF/HCC Program Affiliation
Member, Lung Cancer ProgramMember, Cancer Nursing Research Program
Member, Palliative Care Program
Research Abstract
Major research interests are tobacco control, smoking cessation interventions, symptom management, and quality of life during treatment for cancer with a particular emphasis on lung cancer.Publications
- Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, Danao LL, Elashoff D. Tobacco use in women with lung cancer. Ann Behav Med 2007 May-Jun; 33(3):242-50
PMID: 17600451 - Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, Danao LL. Challenges of recruitment and retention in multisite clinical research. Cancer Nurs 2003 Oct; 26(5):376-84; quiz 385-6
PMID: 14710799 - Sarna L, Cooley ME, Danao L. The global epidemic of tobacco and cancer. Semin Oncol Nurs 2003 Nov; 19(4):233-43
PMID: 14702857 - Cooley ME, Short TH, Moriarty HJ. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology 2003 Oct-Nov; 12(7):694-708
PMID: 14502594 - Cooley ME, Short TH, Moriarty HJ. Patterns of symptom distress in adults receiving treatment for lung cancer. J Palliat Care 2002 Fall; 18(3):150-9
PMID: 12418365 - Cooley ME, Kaiser LR, Abrahm JL, Giarelli E. The silent epidemic: tobacco and the evolution of lung cancer and its treatment. Cancer Invest 2001; 19(7):739-51
PMID: 11577815




